News
Optimal Folate Intake in Elderly Women May Help Reduce Osteoporosis Risk
2 September 2024
Research indicates that up to 20% of bone loss can happen during menopause. Osteoporosis is often called "a silent disease" and is usually detected by a fracture or by measuring the reduction of bone density.
Quatrefolic® may help reduce osteoporosis risk by normalising the homocysteine levels, an amino acid that supports bone integrity.
Quatrefolic® may help reduce osteoporosis risk by normalising the homocysteine levels, an amino acid that supports bone integrity.
In a recent study, women aged 60 years and older who consumed an optimal amount of folate were found to have a lower chance of developing osteoporosis. Osteoporosis is a common issue in older women, particularly after menopause, which can lead to an increased risk of fractures and other health concerns.
The research highlights the importance of prioritizing optimal folate intake through a nutrient-rich diet and targeted supplementation. By reducing the risk of osteoporosis and other age-related health issues, older women can enjoy a higher quality of life and maintain their independence.
Active form of folate: 5-MTHF
A recent study published in BMC Musculoskeletal Disorders in China explored the relationship between folate intake and osteoporosis risk among postmenopausal women. It confirmed that folate could protect against osteoporosis in this woman’s life stage.
In particular, active folate normalizes the homocysteine and reduces oxidative stress.
Supplementation with active folate 5-MTHF, such as Quatrefolic®, bypasses the entire folate metabolization process, and 5-MTHF is directly absorbed to exert its biological activity and advantages.
